Ottobock SE & Co KGaA OBCK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €50.00
- Day Range
- €49.25–52.20
- 52-Week Range
- €45.56–76.35
- Bid/Ask
- €50.30 / €50.60
- Shares Outstanding
- 63.99M
- Market Cap
- €3.18B
- Volume/Avg
- 5,847 / 17,111
Key Statistics
- Price/Earnings (Normalized)
- 20.27
- Price/Sales
- 1.86
- Dividend Yield (Trailing)
- 1.94%
- Dividend Yield (Forward)
- 1.94%
- Dividend Payment Schedule
- May
- Total Yield
- 1.94%
Company Profile
Ottobock SE & Co KGaA is a medical technology company. It specializes in healthcare products and solutions designed to improve mobility and quality of life for people with disabilities or limited mobility. The company's portfolio includes prosthetics, orthotics, neuro-orthotics, rehabilitation products, wheelchairs, and bionic exoskeletons. The company manages its business activities through the operating segments EMEA (Europe, Middle East and Africa), Americas (North and South America) and APAC (Asia Pacific). The company develops, produces and distributes medical technology products and components in these regions and operates an extensive network of patient care facilities. The majority of revenue is derived from the EMEA segment.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- —
- Total Number of Employees
- 9,454
- Website
- https://corporate.ottobock.com
Valuation
|
Metric
|
OBCK
|
|---|---|
Price/Earnings (Normalized) | 20.27 |
Price/Book Value | 8.15 |
Price/Sales | 1.86 |
Price/Cash Flow | 11.92 |
Price/Earnings
OBCK
Financial Strength
|
Metric
|
OBCK
|
|---|---|
Quick Ratio | 0.66 |
Current Ratio | 1.23 |
Interest Coverage | 4.52 |
Quick Ratio
OBCK
Profitability
|
Metric
|
OBCK
|
|---|---|
Return on Assets (Normalized) | 7.52% |
Return on Equity (Normalized) | 44.35% |
Return on Invested Capital (Normalized) | 12.85% |
Return on Assets
OBCK
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|qsM<C!S | LOCK|&K& | $157B | |||
| Becton Dickinson & Co
BDX
| LOCK|HB | LOCK|sfF@L | $55B | |||
| ResMed Inc
RMD
| LOCK|^V<^?<?K | LOCK|Bt>f@ | $36B | |||
| Alcon Inc
ALC
| LOCK|zVMYd#^ | LOCK|GP@C | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|CG<l?# | LOCK|dLR^ | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|f&SRWb!^ | LOCK|DNT | $28B | |||
| Solventum Corp
SOLV
| LOCK|DWQr^Yl | LOCK|F$ | $15B | |||
| Baxter International Inc
BAX
| LOCK|rC& | LOCK|^yR?M | $13B | |||
| The Cooper Companies Inc
COO
| LOCK|Y@X<%R | LOCK|@^X%f | $12B | |||
| Repligen Corp
RGEN
| LOCK|g>^$$>V> | LOCK|L?zF! | $11B |
United States